News
- Author:
- Susan London
Publish date: June 8, 2018
CHICAGO – Three blood-based assays for circulating cell-free DNA detected lung cancer of stage I-IIIA had sensitivities of 38%-51% and specificitie...
News
- Author:
- Susan London
Publish date: June 6, 2018
CHICAGO – Female patients with H&N cancer had almost twice the ratio of cancer deaths to noncancer deaths.
News
- Author:
- Susan London
Publish date: June 6, 2018
CHICAGO – Practice-changing data show that most women with HR-positive, HER2-negative, early-stage breast cancer who have an intermediate recurrenc...
Video
- Author:
- Susan London
Publish date: June 3, 2018
CHICAGO - Lead study author Dr. Gianni Bisogno discusses the practice changing results and describes plans for a new trial to explore alternate mai...
Video
- Author:
- Susan London
Publish date: June 3, 2018
CHICAGO - Lead study author Dr. Joseph A. Sparano discusses the implications of the new data for decision-making and future plans for the tumor sam...
News
- Author:
- Susan London
Publish date: June 3, 2018
CHICAGO – Atezolizumab prolongs PFS by about a month, and patients derived benefit regardless of the level of PD-L1 expression.
Video
- Author:
- Susan London
Publish date: June 2, 2018
CHICAGO - Dr. Geoffrey R. Oxnard discusses interim results from the Circulating Cell-Free Genome Atlas project and ongoing work to bring the blood-...
Video
- Author:
- Susan London
Publish date: June 2, 2018
CHICAGO - Dr. Todd Yezefski discusses the drivers of cost disparities and implications for policy makers.
Video
- Author:
- Susan London
Publish date: June 2, 2018
CHICAGO - Senior study author Dr. Jed A. Katzel discusses ongoing research to understand the reasons behind the apparent disparities.
News
- Author:
- Susan London
Publish date: May 23, 2018
In a randomized trial, both CBT-I and acupuncture reduced insomnia severity among cancer survivors, but the former had the edge.
News
- Author:
- Susan London
Publish date: May 23, 2018
The annual rate of LDCT screening for lung cancer among eligible current and former heavy smokers was just 1.9% in 2016 across the United States.
News
- Author:
- Susan London
Publish date: May 22, 2018
The CYCORE system, which harnesses wireless sensor and mobile technology to remotely monitor vitals and symptoms, reduces symptom severity in patie...
News
- Author:
- Susan London
Publish date: May 19, 2018
Disease-free survival was similarly high whether women received adjuvant trastuzumab for the current standard of 12 months or for just 6 months.
News
- Author:
- Susan London
Publish date: May 19, 2018
More than 8 in 10 youth were still alive and free of disease 4 years after starting combinations of methotrexate and/or nelarabine with chemo.
News
- Author:
- Susan London
Publish date: May 17, 2018
NGS at the time of metastatic NSCLC diagnosis could save millions of dollars relative to more conservative testing strategies, and results become a...
